Multiple Sclerosis Our supporting partners do not constitute an endorsement of the content on this page.
-
Multiple Sclerosis
Ofatumumab – A Potential Subcutaneous B-cell Therapy for Relapsing Multiple Sclerosis
Ron MiloEuropean Neurological Review. 2020;15(1):Epub ahead of publication -
Multiple Sclerosis
Ozanimod in Multiple Sclerosis
Beyza Ciftci-Kavaklioglu , E Ann YehEuropean Neurological Review. 2019;14(2):73–9 DOI: https://doi.org/10.17925/ENR.2019.14.2.73 -
Multiple Sclerosis
Exploring the Role of the Microbiome in Multiple Sclerosis
Lloyd Kasper, Tanuja Chitnis, Mirla Avila, Nicole Sconzo, Raymond Ashton, Mark RamettaUS Neurology. 2019:15(2):82–90 DOI: https://doi.org/10.17925/USN.2019.15.2.82 -
Multiple Sclerosis
Discontinuation of Disease-modifying Treatments in Relapsing-remitting Multiple Sclerosis – A Systematic Literature Review of Observational Studies
Gerard T Harty, Schiffon L Wong, Michael Tang, Sangeeta BudhiaEuropean Neurological Review. 2019:14(1):36–43 DOI: https://doi.org/10.17925/ENR.2019.14.1.36
